Epidemiology and outcome of tuberculosis in immunocompromised patients

Abstract EN

The United States Renal Data System showed 1.2% and 1.6% incidences of tuberculosis (TB) in patients on peritoneal dialysis and hemodialysis (HD), respectively.

Kidney transplant (KTX) patients have higher rates.

We studied the epidemiology and outcome of TB in patients with kidney dysfunction in a tertiary care hospital in the past decade.

We examined data of patients with TB with and without kidney dysfunction from 2006 to 2015 through an electronic system.

Statistical analysis was completed using Stata software, Chicago, IL, USA.

We found 581 patients with active TB of whom 37 had renal dysfunction including chronic kidney disease, HD, and KTX.

No difference was found in the prevalence, age, or gender predilection.

The age ranged from 1 to 95 with a mean (standard deviation) of 38.6 (21.1) years.

The incidence of TB is 3 per 100,000.

The number of patients per year with active TB ranges from 52 to 128 and 3 to 4 in the general population and kidney dysfunction group, respectively.

Sixty-five percent of patients with kidney dysfunction had pulmonary TB, 5% had pleurisy, and 30% had extrapulmonary TB.

Eighty-four percent of patients with kidney dysfunction completed the course of treatment with 16% treatment failure and 0.4% developed multidrug-resistant TB; 8% were lost to follow-up and 8% died during the treatment period.

This study showed no gender predilection for TB in the general population and immunocompromised.

Duration of symptoms before diagnosis of TB was shorter in kidney dysfunction patients in comparison to the general population.

TB cultures were the most positive tests whereas bronchoalveolar lavage and skin test were the least positive for detecting TB in the kidney dysfunction group.

Improvement in registries and screening is required to enhance the capturing rate and detection among this group, as well as providing accurate data